British Journal of Anaesthesia, 2001, Vol. 87, No. 6 905-911
© 2001 The Board of Management and Trustees of the British Journal of Anaesthesia
Laboratory Investigations |
One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo
1Klinik für Anaesthesiologie, Universitätsklinikum and 2Physiologisches Institut I, Heinrich-Heine-Universität, Postfach 101007, D-40001 Düsseldorf, Germany*Corresponding author
Volatile anaesthetics protect the heart against reperfusion injury. We investigated whether the cardioprotection induced by sevoflurane against myocardial reperfusion injury was concentration-dependent. Fifty-eight 
-chloralose anaesthetized rats were subjected to 25 min of coronary artery occlusion followed by 90 min of reperfusion. Sevoflurane was administered for the first 15 min of reperfusion at concentrations corresponding to 0.75 (n=11), 1.0 (n=11), 1.5 (n=13), or 2.0 MAC (n=12). Eleven rats served as untreated controls. Left ventricular peak systolic pressure (LVPSP, tipmanometer) and cardiac output (CO, flowprobe) was measured. Infarct size (IS, triphenyltetrazolium staining) was determined as percentage of the area at risk. Baseline LVPSP was 131 (126–135) mm Hg (mean (95% confidence interval)) and CO 33 (31–36) ml min–1, similar in all groups. During early reperfusion, sevoflurane reduced LVPSP in a concentration-dependent manner to 78 (67–89)% of baseline at 0.75 MAC (not significant vs controls 99 (86–112)%), 71 (62–80)% at 1 MAC (P<0.05), 66 (49–83)% at 1.5 MAC (P<0.05) and 56 (47–65)% at 2 MAC (P<0.05). CO remained constant. While 0.75 MAC of sevoflurane had no effect on IS (34 (27–41)% of the area at risk) compared with controls (38 (31–45)%, P=0.83), 1.0 MAC reduced IS markedly to 23 (17–30)% (P<0.05). Increasing the concentration to 1.5 MAC (23 (17–30)%) and 2 MAC (23 (13–32)%, both P<0.05 vs controls) had no additional protective effect. One MAC sevoflurane protected against myocardial reperfusion injury. Increasing the sevoflurane concentration above 1 MAC resulted in no further protection.
Br J Anaesth 2001; 87: 905–11
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Frassdorf, S. De Hert, and W. Schlack Anaesthesia and myocardial ischaemia/reperfusion injury Br. J. Anaesth., July 1, 2009; 103(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Huhn, A. Heinen, N. C. Weber, S. Hieber, M. W. Hollmann, W. Schlack, and B. Preckel Helium-induced late preconditioning in the rat heart in vivo Br. J. Anaesth., May 1, 2009; 102(5): 614 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Huhn, A. Heinen, N. C. Weber, M. W. Hollmann, W. Schlack, and B. Preckel Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore Br. J. Anaesth., April 1, 2008; 100(4): 465 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yue, B. Roth Z'graggen, S. Blumenthal, S. B. Neff, L. Reyes, C. Booy, M. Steurer, D. R. Spahn, T. A. Neff, E. R. Schmid, et al. Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro Eur. Respir. J., January 1, 2008; 31(1): 118 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Deyhimy, N. W. Fleming, I. G. Brodkin, and H. Liu Anesthetic Preconditioning Combined with Postconditioning Offers No Additional Benefit Over Preconditioning or Postconditioning Alone Anesth. Analg., August 1, 2007; 105(2): 316 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Obal, K. Rascher, C. Favoccia, S. Dettwiler, and W. Schlack Post-conditioning by a short administration of desflurane reduced renal reperfusion injury after differing of ischaemia times in rats Br. J. Anaesth., December 1, 2006; 97(6): 783 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Symons and P. S. Myles Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis Br. J. Anaesth., August 1, 2006; 97(2): 127 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cromheecke, V. Pepermans, E. Hendrickx, S. Lorsomradee, P. W. ten Broecke, B. A. Stockman, I. E. Rodrigus, and S. G. De Hert Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth. Analg., August 1, 2006; 103(2): 289 - 96, table of contents. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Obal, S. Dettwiler, C. Favoccia, H. Scharbatke, B. Preckel, and W. Schlack The Influence of Mitochondrial KATP-Channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat In Vivo Anesth. Analg., November 1, 2005; 101(5): 1252 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. De Hert, F. Turani, S. Mathur, and D. F. Stowe Cardioprotection with Volatile Anesthetics: Mechanisms and Clinical Implications Anesth. Analg., June 1, 2005; 100(6): 1584 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bein, J. Renner, D. Caliebe, J. Scholz, A. Paris, S. Fraund, W. Zaehle, and P. H. Tonner Sevoflurane but Not Propofol Preserves Myocardial Function During Minimally Invasive Direct Coronary Artery Bypass Surgery Anesth. Analg., March 1, 2005; 100(3): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Obal, N. C. Weber, K. Zacharowski, O. Toma, S. Dettwiler, J. I. Wolter, M. Kratz, J. Mullenheim, B. Preckel, and W. Schlack Role of protein kinase C-{varepsilon} (PKC{varepsilon}) in isoflurane-induced cardioprotection Br. J. Anaesth., February 1, 2005; 94(2): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Haelewyn, L. Zhu, J. L. Hanouz, E. Persehaye, S. Roussel, P. Ducouret, and J. L. Gerard Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium Br. J. Anaesth., April 1, 2004; 92(4): 552 - 557. [Abstract] [Full Text] [PDF]
|
|